These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 26475632

  • 1. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma.
    Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, Pearson SA, Leggett B, Whitehall V.
    Gut; 2017 Jan; 66(1):97-106. PubMed ID: 26475632
    [Abstract] [Full Text] [Related]

  • 2. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.
    Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD.
    Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485
    [Abstract] [Full Text] [Related]

  • 3. Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation.
    Yachida S, Mudali S, Martin SA, Montgomery EA, Iacobuzio-Donahue CA.
    Am J Surg Pathol; 2009 Dec; 33(12):1823-32. PubMed ID: 19745699
    [Abstract] [Full Text] [Related]

  • 4. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, Amorosino M, Farraye FA.
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [Abstract] [Full Text] [Related]

  • 5. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH, Bae JM, Cho NY, Kang GH.
    Oncotarget; 2016 Mar 22; 7(12):14095-111. PubMed ID: 26883113
    [Abstract] [Full Text] [Related]

  • 6. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
    Naito T, Nosho K, Ito M, Igarashi H, Mitsuhashi K, Yoshii S, Aoki H, Nomura M, Sukawa Y, Yamamoto E, Adachi Y, Takahashi H, Hosokawa M, Fujita M, Takenouchi T, Maruyama R, Suzuki H, Baba Y, Imai K, Yamamoto H, Ogino S, Shinomura Y.
    World J Gastroenterol; 2014 Aug 07; 20(29):10050-61. PubMed ID: 25110432
    [Abstract] [Full Text] [Related]

  • 7. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
    Kim KM, Lee EJ, Kim YH, Chang DK, Odze RD.
    Am J Surg Pathol; 2010 May 07; 34(5):667-75. PubMed ID: 20305537
    [Abstract] [Full Text] [Related]

  • 8. A clinicopathological and molecular analysis of 200 traditional serrated adenomas.
    Bettington ML, Walker NI, Rosty C, Brown IS, Clouston AD, McKeone DM, Pearson SA, Klein K, Leggett BA, Whitehall VL.
    Mod Pathol; 2015 Mar 07; 28(3):414-27. PubMed ID: 25216220
    [Abstract] [Full Text] [Related]

  • 9. [Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].
    Huang WT, Qiu T, Ling Y, Shi SS, Guo L, Zheng B, Lü N, Ying JM.
    Zhonghua Bing Li Xue Za Zhi; 2013 Oct 07; 42(10):655-9. PubMed ID: 24433726
    [Abstract] [Full Text] [Related]

  • 10. A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix.
    Yantiss RK, Panczykowski A, Misdraji J, Hahn HP, Odze RD, Rennert H, Chen YT.
    Am J Surg Pathol; 2007 Nov 07; 31(11):1742-53. PubMed ID: 18059232
    [Abstract] [Full Text] [Related]

  • 11. Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps.
    Sandmeier D, Benhattar J, Martin P, Bouzourene H.
    Histopathology; 2009 Aug 07; 55(2):206-13. PubMed ID: 19694828
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M, Mitsuhashi K, Igarashi H, Nosho K, Naito T, Yoshii S, Takahashi H, Fujita M, Sukawa Y, Yamamoto E, Takahashi T, Adachi Y, Nojima M, Sasaki Y, Tokino T, Baba Y, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y.
    Int J Cancer; 2014 Dec 01; 135(11):2507-15. PubMed ID: 24752710
    [Abstract] [Full Text] [Related]

  • 13. Endoscopic and molecular characterization of colorectal sessile serrated adenoma/polyps with cytologic dysplasia.
    Tanaka Y, Yamano HO, Yamamoto E, Matushita HO, Aoki H, Yoshikawa K, Takagi R, Harada E, Nakaoka M, Yoshida Y, Eizuka M, Sugai T, Suzuki H, Nakase H.
    Gastrointest Endosc; 2017 Dec 01; 86(6):1131-1138.e4. PubMed ID: 28501592
    [Abstract] [Full Text] [Related]

  • 14. Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features.
    Rosty C, Young JP, Walsh MD, Clendenning M, Walters RJ, Pearson S, Pavluk E, Nagler B, Pakenas D, Jass JR, Jenkins MA, Win AK, Southey MC, Parry S, Hopper JL, Giles GG, Williamson E, English DR, Buchanan DD.
    Mod Pathol; 2013 Jun 01; 26(6):825-34. PubMed ID: 23348904
    [Abstract] [Full Text] [Related]

  • 15. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.
    Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ.
    Am J Surg Pathol; 2004 Nov 01; 28(11):1452-9. PubMed ID: 15489648
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and molecular characterisation of the sessile serrated adenoma in a subset of the Chinese population.
    Qiu Y, Fu X, Zhang W, Xu Y, Xiao L, Chen X, Shi L, Zhou X, Xia G, Peng Y, Deng M.
    J Clin Pathol; 2014 Jun 01; 67(6):491-8. PubMed ID: 24570042
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
    Hu H, Chang DT, Nikiforova MN, Kuan SF, Pai RK.
    Am J Surg Pathol; 2013 Nov 01; 37(11):1660-70. PubMed ID: 23887157
    [Abstract] [Full Text] [Related]

  • 18. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
    Farchoukh L, Kuan SF, Dudley B, Brand R, Nikiforova M, Pai RK.
    Am J Surg Pathol; 2016 Oct 01; 40(10):1390-9. PubMed ID: 27438990
    [Abstract] [Full Text] [Related]

  • 19. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.
    Rosty C, Buchanan DD, Walsh MD, Pearson SA, Pavluk E, Walters RJ, Clendenning M, Spring KJ, Jenkins MA, Win AK, Hopper JL, Sweet K, Frankel WL, Aronson M, Gallinger S, Goldblatt J, Woodall S, Arnold J, Walker NI, Jass JR, Parry S, Young JP.
    Am J Surg Pathol; 2012 Jun 01; 36(6):876-82. PubMed ID: 22510757
    [Abstract] [Full Text] [Related]

  • 20. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon.
    Oh K, Redston M, Odze RD.
    Hum Pathol; 2005 Jan 01; 36(1):101-11. PubMed ID: 15712188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.